Investor
The company announced its first funding round at the Health 2.0 VentureConnect event in San Francisco yesterday.
The pharma company walks away with the full license for Proteus' mental health treatment adherence technology.
A new report published by Research2Guidance found that femtech companies have raised over $220 million since 2011. The group predicts that number will jump to $297 million by 2024.
The hefty price tag will allow Teladoc Health to deliver single, unified virtual care offering "across all sites of care."
Dexcom G6 users will now be able to integrate their continuous glucose monitor to the Livongo platform for more personalized insights and coaching.
The new funding was led by Caffeinated Capital with participation from Venrock, Obvious Ventures, Creandum, Playground Global and SciFi VC.
The company will be pumping the funds into its tech platform, and will be growing its engineering, sales and support capabilities.
Funding for the tech-enabled provider was led by BlueMountain Capital Management.
Rock Health's annual funding report revealed that the average size of digital health deals decreased in 2019, as did the total funding for the year.
The subscription fitness class booking platform said that these new funds will drive further expansion in existing and new markets.